Should we treat HER, too?
Hayes
D F
DF
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism
D000911:Antibodies, Monoclonal; D018719:Erb-b2 Receptor Tyrosine Kinases